Keane's Corner VL

Journal Club: Cardiovascular Morbidity Associated with Gonadotropin Releasing Hormones Agonist and an Antagonist

Details
Thomas Keane provides a journal club review on the article, "Cardiovascular Morbidity Associated with Gonadotropin Releasing Hormones Agonist and an Antagonist", published in the European Association of Urology. The hypothesis and approach for this article includes a discussion around if a GnRH antagonist produce the same risk of cardiovascular complication when compared to an LHRH agonist. Also,...

Role of the Gonadotrophin-Releasing Hormone Antagonists and Advanced Hormone-Dependent Prostate Cancer - Journal review

Details
This edition of Keane’s Corner is a Journal Club discussion on the article, “The Role of the Gonadotrophin-Releasing Hormone Antagonists in the Treatment of Patients with Advanced Hormone-Dependent Prostate Cancer in the UK”, published in the World Journal of Urology. Authors: Derek J. Rosario, Patrick Davey, James Green, Damien Greene, Bruce Turner, Heather Payne and Mike Kirby An overview of the...

Cardiovascular Effects of Androgen Deprivation Therapy for the Treatment of Prostate Cancer

Details
A journal club article review presented by Thomas Keane, MD. “Cardiovascular Effects of Androgen Deprivation Therapy for the Treatment of Prostate Cancer: ABCDE Steps to Reduce Cardiovascular Disease in Patients with Prostate Cancer”. Written by: Nirmanmoh Bhatia, Marilia Santos, Lee W. Jones, Joshua A. Beckman, David F. Penson, Alicia K. Morgans and Javid Moslehi In this presentation of the journ...

ASCO 2016: Keane's Corner blog - Bladder Cancer.

Details
Thomas Keane, Editor-in-Chief UroToday.com, discusses new treatment advances for patients with metastatic urothelial cancer. The standard of care for patients with locally advanced or metastatic urothelial cancer is currently cisplatin-based chemotherapy, which is the only therapy ever shown to improve survival in this setting. However, nearly half of patients diagnosed with this disease will not...

AUA 2016 Roundup: Prostate Cancer

Details
Thomas Keane discusses key highlights from the AUA 2016

Focus on ASCO GU 2016

Details
Thomas E. Keane, MBBCh, FRCSI, FACS, is Professor and Chairman of the Department of Urology at the Medical University of South Carolina in Charleston. Dr. Keane specializes in managing prostate, bladder, and renal cancers. An avid researcher, Dr. Keane has served as principal investigator or coinvestigator on more than 20 major clinical and preclinical studies, funded by grants from the National I...

2016 ASCO GU: Renal Cancer Review

Details
Thomas E. Keane, MBBCh, FRCSI, FACS, is Professor and Chairman of the Department of Urology at the Medical University of South Carolina in Charleston. Dr. Keane specializes in managing prostate, bladder, and renal cancers. An avid researcher, Dr. Keane has served as principal investigator or coinvestigator on more than 20 major clinical and preclinical studies, funded by grants from the National I...

2016 ASCO GU: Prostate Cancer Conference Highlights

Details
Thomas E. Keane, MBBCh, FRCSI, FACS, is Professor and Chairman of the Department of Urology at the Medical University of South Carolina in Charleston. Dr. Keane specializes in managing prostate, bladder, and renal cancers. An avid researcher, Dr. Keane has served as principal investigator or coinvestigator on more than 20 major clinical and preclinical studies, funded by grants from the National I...